Zobrazeno 1 - 10
of 18 931
pro vyhledávání: '"Visseren"'
Autor:
Daniël Duijzer, Maria A. de Winter, Marc Carrier, Alexander T. Cohen, John-Bjarne Hansen, Karin A.H. Kaasjager, Ajay K. Kakkar, Saskia Middeldorp, Henrik T. Sørensen, Frank L.J. Visseren, Philip S. Wells, Jannick A.N. Dorresteijn, Mathilde Nijkeuter
Publikováno v:
Research and Practice in Thrombosis and Haemostasis, Vol 8, Iss 7, Pp 102569- (2024)
Background: After 3 months of anticoagulation for venous thromboembolism (VTE), the decision needs to be made whether to stop anticoagulation or extend treatment indefinitely. The VTE-PREDICT calculator can be used to estimate individual risks of VTE
Externí odkaz:
https://doaj.org/article/762594d3a38a49cfa6a9cbbcee03a280
Autor:
Westerink J; University Medical Center Utrecht, Vascular Medicine, The Netherlands., Visseren F; University Medical Center Utrecht, Vascular Medicine, The Netherlands.
Publikováno v:
Arteriosclerosis, thrombosis, and vascular biology [Arterioscler Thromb Vasc Biol] 2017 May; Vol. 37 (5), pp. e53.
Autor:
Jannick A.N. Dorresteijn, MD, PhD, MSc, Steven H.J. Hageman, MD, PhD, MSc, Frank L.J. Visseren, MD, PhD, Deepak L. Bhatt, MD, MPH, MBA
Publikováno v:
JACC: Advances, Vol 3, Iss 9, Pp 101089- (2024)
Externí odkaz:
https://doaj.org/article/c7e68e008bb7474da86264e622ea27d7
Autor:
van Apeldoorn, Joshua A.N., Hageman, Steven H.J., Harskamp, Ralf E., Agyemang, Charles, van den Born, Bert-Jan H., van Dalen, Jan Willem, Galenkamp, Henrike, Hoevenaar-Blom, Marieke P., Richard, Edo, van Valkengoed, Irene G.M., Visseren, Frank L.J., Dorresteijn, Jannick A.N., Moll van Charante, Eric P.
Publikováno v:
In International Journal of Cardiology 15 December 2024 417
Autor:
Duijzer, Daniël, de Winter, Maria A., Carrier, Marc, Cohen, Alexander T., Hansen, John-Bjarne, Kaasjager, Karin A.H., Kakkar, Ajay K., Middeldorp, Saskia, Sørensen, Henrik T., Visseren, Frank L.J., Wells, Philip S., Dorresteijn, Jannick A.N., Nijkeuter, Mathilde
Publikováno v:
In Research and Practice in Thrombosis and Haemostasis October 2024 8(7)
Autor:
Jan Westerink, Frank L.J. Visseren
Publikováno v:
Arteriosclerosis, thrombosis, and vascular biology. 37(5)
We read with great interest the study of Takase et al1 on the addition of ezetimibe to lipid-lowering therapy (simvastatin) on coronary artery endothelial function. It shows that addition of ezetimibe not only lowers low-density lipoprotein cholester
Autor:
Westerink, Jan, Visseren, Frank
Publikováno v:
Arteriosclerosis, Thrombosis and Vascular Biology, 37(5). Lippincott Williams and Wilkins
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::107d2bf4628fef7feb76853363f3b461
https://dspace.library.uu.nl/handle/1874/349660
https://dspace.library.uu.nl/handle/1874/349660
Publikováno v:
In Atherosclerosis January 2025 400
Publikováno v:
In Ecological Economics January 2025 227
Publikováno v:
Atherosclerosis Plus, Vol 55, Iss , Pp 5-11 (2024)
Background and aims: – Pseudoxanthoma elasticum (PXE) is a rare genetic disease caused by pathogenic mutations in the ABCC6 gene, resulting in low values of inorganic pyrophosphate (PPi). While low PPi is thought to contribute to arterial calcifica
Externí odkaz:
https://doaj.org/article/6b633572d2964dc18c327a82fb03d3c1